

![]() |
|||||||||||||
|
| All | Since 2021 | |
| Citation | 7304 | 4079 |
| h-index | 28 | 23 |
| i10-index | 181 | 77 |
Submit Article
Search
News & Updation
COMPREHENSIVE REVIEW ON THE ANTIDIABETIC POTENTIAL OF TRIGONELLA FOENUM-GRAECUM(FENUGREEK): PHYTOCHEMICAL AND PHARMACOLOGICAL PERSPECTIVES
Rushika Godambe*, Tejaswini Asawe, Pratiksha Barde, Bhumika Pawar, Poonam Khandagale, Kamini Patil
ABSTRACT Hyperglycemia, characterized by an abnormal elevation of blood glucose levels, represents a core pathophysiological feature of Diabetes Mellitus and poses a severe global public health challenge. This review paper provides a comprehensive overview of the multifactorial etiology, molecular pathophysiology, and current management strategies associated with hyperglycemia. The etiology spans complex genetic predispositions, sedentary lifestyle choices, autoimmune-mediated pancreatic \beta-cell destruction, and prominent iatrogenic factors, particularly drug-induced insulin resistance caused by glucocorticoids and atypical antipsychotics. At the cellular level, chronic glucose elevation triggers metabolic deviations into the polyol and advanced glycation end-products (AGEs) pathways, generating severe mitochondrial oxidative stress that drives progressive microvascular and macrovascular complications. Effective management necessitates robust diagnostic criteria involving fasting plasma glucose and glycated hemoglobin (HbA1c) tracking, alongside diverse pharmacological interventions ranging from standard biguanides to novel targeted therapies. Understanding these integrated cellular mechanisms and drug interactions is crucial for optimizing therapeutic protocols and developing future targeted drug delivery systems. Keywords: Hyperglycemia, Pathophysiology, Oxidative Stress, InsulinResistance, Drug-Induced hyperglycemia Pharmacological. [Download Article] [Download Certifiate] |
